Treatment Options for Eczema
Topical corticosteroids are the mainstay of treatment for eczema, with the least potent preparation that effectively controls symptoms being recommended as first-line therapy. 1, 2, 3
First-Line Treatment
Topical Corticosteroids
- Choose the least potent preparation that effectively controls the eczema 1, 2
- For facial eczema, use mild to moderate potency corticosteroids due to thinner skin in this area 1
- Apply treatment once or twice daily - once-daily application of potent corticosteroids is equally effective as twice-daily application 1, 4
- Regular application for 2-3 weeks is typically required depending on severity 5
- Potent and moderate topical corticosteroids are more effective than mild corticosteroids for moderate to severe eczema 4, 6
Skin Care and Trigger Management
- Apply emollients immediately after bathing to provide a surface lipid film that retards evaporative water loss 1, 2, 3
- Use dispersible cream as a soap substitute instead of regular soaps and detergents that remove natural skin lipids 1, 2
- Avoid extreme temperatures and irritant clothing (such as wool); cotton clothing is preferred 1, 2
- Keep nails short to minimize damage from scratching and reduce risk of secondary infection 1, 2
Second-Line Treatment Options
Alternative Topical Preparations
- Ichthammol (1% in zinc ointment) for lichenified eczema - less irritant than coal tars 1, 2
- Coal tar solution (1% in hydrocortisone ointment) is generally preferred to crude coal tar 1, 2
- Topical calcineurin inhibitors (tacrolimus 0.1%, tacrolimus 0.03%, pimecrolimus 1%) are effective alternatives, particularly for facial eczema 6
Antihistamines
- Sedating antihistamines can be useful as a short-term adjuvant to topical treatment during relapses with severe pruritus, primarily for their sedative properties 1, 2
- Non-sedating antihistamines have little to no value in treating eczema 1, 2
Management of Secondary Infections
Bacterial Infections
- Treat overt secondary bacterial infections with appropriate antibiotics 1, 3
- Flucloxacillin is usually most appropriate for Staphylococcus aureus 1, 3
- Phenoxymethylpenicillin for β-hemolytic streptococci 1
- Erythromycin for penicillin-allergic patients 1, 3
Viral Infections
- For herpes simplex infection (eczema herpeticum), administer oral acyclovir early in the disease course 1, 3
- In ill, feverish patients, acyclovir should be given intravenously 1
Third-Line Treatment Options
Phototherapy
- Consider phototherapy for moderate to severe eczema not responding to first-line treatments 1, 6
- Narrowband UVB may be considered, showing a 75% reduction in mean severity scores with 17% clearance rate in some studies 3
- Oral PUVA therapy has shown significant improvement or clearance in 81-86% of patients with hand and foot eczema 3
Systemic Treatments
- Systemic corticosteroids have a limited but definite role in occasional patients with severe atopic eczema 1
- Should not be considered for maintenance treatment until all other avenues have been explored 1, 7
Prevention of Relapse
- Weekend (proactive) topical corticosteroid therapy significantly reduces the likelihood of relapse compared to no treatment (25% vs 58%) 4
Important Considerations and Precautions
Skin Thinning Risk
- Short-term use of topical corticosteroids (1-16 weeks) shows no significant evidence of increased skin thinning, even with potent formulations 6
- Longer-term use (6-60 months) may increase risk of skin thinning with mild to potent TCS 6
- Use topical corticosteroids cautiously on thin skin areas, particularly the face 1, 5
Systemic Absorption
- Systemic absorption of topical corticosteroids can produce hypothalamic-pituitary-adrenal (HPA) axis suppression 5
- Risk factors for systemic absorption include: application of potent steroids, use over large surface areas, prolonged use, and occlusive dressings 5
- Children may absorb proportionally larger amounts and be more susceptible to systemic toxicity 5
Special Populations
- In children, topical corticosteroids should be used cautiously due to risk of pituitary-adrenal axis suppression 2, 5
- For pregnant women, topical corticosteroids should be used only if the potential benefit justifies the potential risk to the fetus 5